Clinical Trials Logo

Fibromyalgia clinical trials

View clinical trials related to Fibromyalgia.

Filter by:

NCT ID: NCT05910372 Recruiting - Fibromyalgia Clinical Trials

Tools for the Differential Diagnosis of Fibromyalgia Based on Cognitive Tasks

Start date: April 25, 2023
Phase:
Study type: Observational

The goal of this observational study is to test for behavioural and neurophysiological biomarkers in fibromyalgia patients. The main questions it aims to answer are: - Is there a measurable decline in working memory? - Could these measures help in fibromyalgia differential diagnosis? Participants will: - perform Color Comparison tasks - perform n-back tasks

NCT ID: NCT05907590 Recruiting - Fibromyalgia Clinical Trials

Proprioception and Interoception in Patients With Fibromyalgia

Start date: July 25, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about interoception and proprioception in patients with fibromyalgia. The main questions it aims to answer are: - Is there a significant difference in interoception between patients with fibromyalgia and healthy controls? - Is there a significant difference in proprioception between patients with fibromyalgia and healthy controls? The participants will perform: - The respiratory occlusion discrimination task - A postural control task where the effect of muscle vibration on center of gravity displacement is examined - The head repositioning accuracy task The participants will also fill out different questionnaires. Researchers will compare healthy controls to see if there is a significant difference.

NCT ID: NCT05907538 Recruiting - Fibromyalgia Clinical Trials

Interoception in Patients With Medically Unexplained Symptoms

Start date: July 25, 2022
Phase:
Study type: Observational

The goal of this observational study is to learn about interoception in patients with stress related syndromes (overstrain, burnout; SRS) and functional disorder (fibromyalgia/ chronic fatigue syndrome; FD). The main questions it aims to answer are: - Is there a significant difference in interoception between patients with SRS and healthy controls? - Is there a significant difference in interoception between patients with FD and healthy controls? - Is there a significant difference in interoception between patients with SRS and FD? The participants will perform the respiratory occlusion discrimination task and have to fill out some questionnaires. Researchers will compare healthy controls to see if there is a significant difference.

NCT ID: NCT05900466 Recruiting - Clinical trials for Fibromyalgia Syndrome

Metformin for Fibromyalgia Symptoms (INFORM Trial)

Start date: April 1, 2023
Phase: Phase 2
Study type: Interventional

The main purpose of the project is to evaluate the safety and efficacy of low dose metformin for improving symptoms associated with fibromyalgia syndrome (FMS) via modulating neuroinflammatory pathways. The investigators hypothesize that FMS patients in the low-dose metformin conditions will show greater improvement in FMS symptoms than those who are in the placebo group. Further, the investigators hypothesize that metformin will increase phosphorylated AMPK in peripheral immune cells of FMS patients and will decrease the transcription of mTORC1, NLRP3 inflammasome, and nociceptive cytokines interleukin 1beta and interleukin 18.

NCT ID: NCT05865522 Recruiting - Massage Therapy Clinical Trials

Massage of the Trapezius Muscle and Foot in Fibromyalgia Patients

Start date: May 18, 2023
Phase: N/A
Study type: Interventional

Objective: This study will be conducted to evaluate the effects of classical massage applied to the trapezius muscle and foot in patients with fibromyalgia on pain, effects of fibromyalgia and quality of life. Material and Method: The research will be carried out with 75 patients with fibromyalgia who refer to Artvin State Hospital Physical Therapy and Rehabilitation outpatient clinic. The patients will be grouped in 3 through simple randomization: trapezius massage (Group A), foot massage (Group B) and control group (Group C). In the physical therapy unit, the patients in Group A will receive a total of 12 sessions of trapezius massage, 2 sessions per week for 6 weeks; the patients in Group B will receive a total of 12 sessions of foot massage, 2 sessions per week for 6 weeks and Group C will not receive massage. Patient information form, VAS pain scale, Revised Fibromyalgia Impact Questionnaire and SF 36 Quality of Life Scale will be used to collect data. Chi-square paired t test, Wilcoxon test, one-way analysis of variance and Kruskal Wallis test will be used in the analysis of data.

NCT ID: NCT05851326 Recruiting - Clinical trials for Myofascial Pain Syndrome - Neck

Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain Syndrome

Start date: May 25, 2023
Phase: N/A
Study type: Interventional

Sonodyn is an investigational device that within this clinical investigation is intended for use in patients suffering from low back pain, tension headache or neck pain, originating from therapy-resistant myofascial pain syndrome. Myofascial pain syndrome is a prevalent pain condition in the adult population and a common cause of pain and dysfunction in the musculoskeletal system. It is a trigger point-induced regional musculoskeletal pain disorder affecting one or more muscles or groups of muscles. Sonodyn is a handheld medical device that combines low-energy ultrasound, electrical and magnetic field stimulation for non-invasive transcutaneous treatment of chronic myofascial pain syndrome. Sonodyn is a battery-operated, rechargeable stimulation device to be placed over specific trigger points for associated pain patterns in the human body. It emits ultrasound, electrical and magnetic stimulation signals with a pre-defined set of parameters for each of the independently operated power sources. The study will follow a prospective, randomized, sham-controlled, double-blind parallel group design. It will be conducted as a multi-center investigation at 6 sites in Austria and Switzerland. Patients are randomized in a 2:1 ratio into Treatment and Control. - Active Sonodyn therapy (Treatment) - No therapy (Sham Control) Two types of Sonodyn devices will be used: a fully functional one for Therapy arm patients that can deliver stimulation, and a non-functional one for Control arm patients that cannot convey any energy signals to the device output. The devices will look fully identical. Randomization will be stratified by study site, pain diagnosis and sex of the patient. For each subject, after a screening phase of 1 week, patients will be treated for 3 weeks with a follow-up of additional 8 weeks, adding up to 12 weeks. During treatment patients will activate their device 3 times a day for 10 minutes each. During screening, treatment and follow-up period, all patients will twice per day report the average and maximum intensity of their pain Numeric Rating Scale (NRS). Patients will also enter the date, amount, and time of intake of rescue medication, if applicable. The primary objective of this study is to assess the impact on pain. Secondary objectives are to compare the performance between active therapy and sham, as well as to correlate changes in pain intensity with other pain related scales.

NCT ID: NCT05850442 Recruiting - Anxiety Disorders Clinical Trials

The Relationship Between Fibromyalgia Syndrome Parameters With Disease-Pain Severity and the Quality Of Life

Start date: April 1, 2023
Phase:
Study type: Observational

In this study, the investigators aim to evaluate the relationship between disease severity, quality of life, anxiety and pain level in patients diagnosed with Fibromyalgia Syndrome (FMS) with the parameters according to the American College of Rheumatology (ACR) 2016 diagnostic criteria. According to the 2016 ACR diagnostic criteria, there are 2 separate scales: Widespread Pain Index (WPI) and Symptom Severity (SS) . The relationship between these 2 parameters and the Fibromyalgia Impact Questionnaire, the World Health Organization Short Quality of Life Questionnaire, and the McGill Melzack Pain Questionnaire and Beck Anxiety Questionnaire will be examined.

NCT ID: NCT05848544 Recruiting - Knee Osteoarthritis Clinical Trials

Efficacy of a Very Low Calories Ketogenic Diet in Obese Patients With Fibromyalgia or Symptomatic Knee Osteoarthritis

KD-FM-OA
Start date: April 2, 2021
Phase: N/A
Study type: Interventional

Adult patients with fibromyalgia or symptomatic knee osteoarthritis and comorbid obesity eligible to a very low calories ketogenic diet will be enrolled in the pilot study

NCT ID: NCT05822856 Recruiting - Clinical trials for Rheumatoid Arthritis

Gut Microbiota: a Player in Chronic Pain in Patients With Rheumatoid Arthritis?

MiSenDol
Start date: July 6, 2023
Phase:
Study type: Observational

Although rheumatoid arthritis (RA) treatments are very effective in reducing inflammation, chronic pain persists in 20 to 30% of patients. The intestinal microbiota can participate on the pain pathways and a decrease in Faecalibacterium has been associated with chronic pain and chronic fatigue. RA patients have an altered gut microbiota or dysbiosis. Among the bacteria that are most often differentially represented between RA and control, Faecalibacterium, was also found less abundant in RA patients. The composition of the gut microbiota has never been evaluated in relation to the clinical phenotype of RA patients and in particular to the presence of a diffuse pain. In this study, investigators will test whether the gut microbiota of RA patients, and in particular the decrease of Faecalibacterium, would promote pain sensitization phenomena, and thus, chronic pain despite the control of joint inflammation.

NCT ID: NCT05814497 Recruiting - Fibromyalgia Clinical Trials

Supraspinal Processing of Sensory Aspects of Pain

SCP
Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The goal of this basic science study is to learn about the brain mechanisms of chronic pain across different chronic pain syndromes in pediatric patients. The main questions it aims to answer are: - Are there shared and distinct brain systems engaged by different forms of pediatric chronic pain? - What are predictors of recovery from chronic pain? - What brain systems are associated with the spread of pain? For this study participants will undergo: - Functional Magnetic Resonance Imaging (fMRI) - Quantitative Sensory Testing - Psychological Assessments